123 related articles for article (PubMed ID: 16048248)
1. Transforming growth factor-beta: importance in long-term peritoneal membrane changes.
Margetts PJ; Oh KH; Kolb M
Perit Dial Int; 2005 Feb; 25 Suppl 3():S15-7. PubMed ID: 16048248
[TBL] [Abstract][Full Text] [Related]
2. Gene transfer of transforming growth factor-beta1 to the rat peritoneum: effects on membrane function.
Margetts PJ; Kolb M; Galt T; Hoff CM; Shockley TR; Gauldie J
J Am Soc Nephrol; 2001 Oct; 12(10):2029-2039. PubMed ID: 11562401
[TBL] [Abstract][Full Text] [Related]
3. Transient overexpression of TGF-{beta}1 induces epithelial mesenchymal transition in the rodent peritoneum.
Margetts PJ; Bonniaud P; Liu L; Hoff CM; Holmes CJ; West-Mays JA; Kelly MM
J Am Soc Nephrol; 2005 Feb; 16(2):425-36. PubMed ID: 15590759
[TBL] [Abstract][Full Text] [Related]
4. Rapamycin inhibits transforming growth factor β-induced peritoneal angiogenesis by blocking the secondary hypoxic response.
Sekiguchi Y; Zhang J; Patterson S; Liu L; Hamada C; Tomino Y; Margetts PJ
J Cell Mol Med; 2012 Aug; 16(8):1934-45. PubMed ID: 22117756
[TBL] [Abstract][Full Text] [Related]
5. Epithelial to mesenchymal transition as a triggering factor of peritoneal membrane fibrosis and angiogenesis in peritoneal dialysis patients.
Aguilera A; Yáñez-Mo M; Selgas R; Sánchez-Madrid F; López-Cabrera M
Curr Opin Investig Drugs; 2005 Mar; 6(3):262-8. PubMed ID: 15816502
[TBL] [Abstract][Full Text] [Related]
6. Calcitriol decreases TGF-β1 and angiotensin II production and protects against chlorhexide digluconate-induced liver peritoneal fibrosis in rats.
Lee CJ; Subeq YM; Lee RP; Liou HH; Hsu BG
Cytokine; 2014 Jan; 65(1):105-18. PubMed ID: 24210651
[TBL] [Abstract][Full Text] [Related]
7. TGF-β1-VEGF-A pathway induces neoangiogenesis with peritoneal fibrosis in patients undergoing peritoneal dialysis.
Kariya T; Nishimura H; Mizuno M; Suzuki Y; Matsukawa Y; Sakata F; Maruyama S; Takei Y; Ito Y
Am J Physiol Renal Physiol; 2018 Feb; 314(2):F167-F180. PubMed ID: 28978530
[TBL] [Abstract][Full Text] [Related]
8. Effect of glucose degradation products on the peritoneal membrane in a chronic inflammatory infusion model of peritoneal dialysis in the rat.
Park SH; Lee EG; Kim IS; Kim YJ; Cho DK; Kim YL
Perit Dial Int; 2004; 24(2):115-22. PubMed ID: 15119632
[TBL] [Abstract][Full Text] [Related]
9. Update on mechanisms of ultrafiltration failure.
Kim YL
Perit Dial Int; 2009 Feb; 29 Suppl 2():S123-7. PubMed ID: 19270200
[TBL] [Abstract][Full Text] [Related]
10. Biocompatibility of peritoneal dialysis fluids: long-term exposure of nonuremic rats.
Musi B; Braide M; Carlsson O; Wieslander A; Albrektsson A; Ketteler M; Westenfeld R; Floege J; Rippe B
Perit Dial Int; 2004; 24(1):37-47. PubMed ID: 15104335
[TBL] [Abstract][Full Text] [Related]
11. Effects of low glucose degradation products peritoneal dialysis fluid on the peritoneal fibrosis and vascularization in a chronic rat model.
Kim CD; Kwon HM; Park SH; Oh EJ; Kim MH; Choi SY; Choi MJ; Kim IS; Park MS; Kim YJ; Kim YL
Ther Apher Dial; 2007 Feb; 11(1):56-64. PubMed ID: 17309576
[TBL] [Abstract][Full Text] [Related]
12. Peritoneal morphological and functional changes associated with platelet-derived growth factor B.
Cina D; Patel P; Bethune JC; Thoma J; Rodriguez-Lecompte JC; Hoff CM; Liu L; Margetts PJ
Nephrol Dial Transplant; 2009 Feb; 24(2):448-57. PubMed ID: 18775895
[TBL] [Abstract][Full Text] [Related]
13. Transforming growth factor β-induced peritoneal fibrosis is mouse strain dependent.
Margetts PJ; Hoff C; Liu L; Korstanje R; Walkin L; Summers A; Herrick S; Brenchley P
Nephrol Dial Transplant; 2013 Aug; 28(8):2015-27. PubMed ID: 22785109
[TBL] [Abstract][Full Text] [Related]
14. Transforming growth factors beta1, beta2 and beta3 and their receptors are differentially expressed in human peritoneal fibroblasts in response to hypoxia.
Saed GM; Collins KL; Diamond MP
Am J Reprod Immunol; 2002 Dec; 48(6):387-93. PubMed ID: 12607775
[TBL] [Abstract][Full Text] [Related]
15. Functional and structural alterations of peritoneum and secretion of fibrotic cytokines in rats caused by high glucose peritoneal dialysis solutions.
Liu Y; Li JF; Liu H; Liu FY; Peng YM; Liu YH; Cheng MC; Chen GC; Zhou X
Ren Fail; 2014 Mar; 36(2):292-9. PubMed ID: 24152223
[TBL] [Abstract][Full Text] [Related]
16. Inflammatory cytokines, angiogenesis, and fibrosis in the rat peritoneum.
Margetts PJ; Kolb M; Yu L; Hoff CM; Holmes CJ; Anthony DC; Gauldie J
Am J Pathol; 2002 Jun; 160(6):2285-94. PubMed ID: 12057931
[TBL] [Abstract][Full Text] [Related]
17. Matrix metalloproteinase 9 is associated with peritoneal membrane solute transport and induces angiogenesis through β-catenin signaling.
Padwal M; Siddique I; Wu L; Tang K; Boivin F; Liu L; Robertson J; Bridgewater D; West-Mays J; Gangji A; Brimble KS; Margetts PJ
Nephrol Dial Transplant; 2017 Jan; 32(1):50-61. PubMed ID: 27190383
[TBL] [Abstract][Full Text] [Related]
18. Nebivolol, a β1-adrenergic blocker, protects from peritoneal membrane damage induced during peritoneal dialysis.
Liappas G; González-Mateo G; Aguirre AR; Abensur H; Albar-Vizcaino P; Parra EG; Sandoval P; Ramírez LG; Del Peso G; Acedo JM; Bajo MA; Selgas R; Sánchez Tomero JA; López-Cabrera M; Aguilera A
Oncotarget; 2016 May; 7(21):30133-46. PubMed ID: 27102153
[TBL] [Abstract][Full Text] [Related]
19. Smad7 transgene attenuates peritoneal fibrosis in uremic rats treated with peritoneal dialysis.
Guo H; Leung JC; Lam MF; Chan LY; Tsang AW; Lan HY; Lai KN
J Am Soc Nephrol; 2007 Oct; 18(10):2689-703. PubMed ID: 17855642
[TBL] [Abstract][Full Text] [Related]
20. Autophagy promotes fibrosis and apoptosis in the peritoneum during long-term peritoneal dialysis.
Wu J; Xing C; Zhang L; Mao H; Chen X; Liang M; Wang F; Ren H; Cui H; Jiang A; Wang Z; Zou M; Ji Y
J Cell Mol Med; 2018 Feb; 22(2):1190-1201. PubMed ID: 29077259
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
